RETRACTED ARTICLE: LncRNA XIST promotes human lung adenocarcinoma cells to cisplatin resistance via let-7i/BAG-1 axis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cell Cycle

• Publication date

  2017-09-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/15384101.2017.1361071PMID 28961027PMCID PMC5731406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functions

  2018cited by this paper
• The Long Non-Coding RNA XIST Controls Non-Small Cell Lung Cancer Proliferation and Invasion by Modulating miR-186-5p

  2017cited by this paper
• Downregulation of miR-224 and let-7i contribute to cell survival and chemoresistance in chronic myeloid leukemia cells by regulating ST3GAL IV expression.

  2017cited by this paper
• Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression

  2017cited by this paper
• Long non-coding RNAs in anti-cancer drug resistance

  2016cited by this paper
• Long non-coding RNAs in cancer drug resistance development.

  2016cited by this paper
• Regulation of osteoblast development by Bcl-2-associated athanogene-1 (BAG-1)

  2016cited by this paper
• Increased expression of long-noncoding RNA ZFAS1 is associated with epithelial-mesenchymal transition of gastric cancer

  2016cited by this paper
• Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer

  2016cited by this paper
• Long non-coding RNA XIST promotes cell growth and invasion through regulating miR-497/MACC1 axis in gastric cancer

  2016cited by this paper
• Abrogating the interplay between IGF2BP1, 2 and 3 and IGF1R by let-7i arrests hepatocellular carcinoma growth

  2016cited by this paper
• Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression

  2016cited by this paper
• Long Non-Coding RNAs in Cancer and Development: Where Do We Go from Here?

  2015cited by this paper
• Mechanisms of breast cancer resistance to anthracyclines or taxanes: an overview of the proposed roles of noncoding RNA

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.

  2015cited by this paper
• The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma

  2015cited by this paper
• Role of BCL2-associated athanogene in resistance to platinum-based chemotherapy in non-small-cell lung cancer

  2015cited by this paper
• Modulation of BAG-1 Expression Alters the Sensitivity of Breast Cancer Cells to Tamoxifen

  2014cited by this paper
• Systems biology of cisplatin resistance: past, present and future

  2014cited by this paper
• The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer Cell

  2013cited by this paper
• The Long Noncoding RNA HOTAIR Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma Cells via downregualtion of p21WAF1/CIP1 Expression

  2013cited by this paper
• Decreased expression of microRNA let-7i and its association with chemotherapeutic response in human gastric cancer

  2012cited by this paper
• CA : A Cancer Journal for Clinicians

  2011cited by this paper
• Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC.

  2011cited by this paper
• Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells

  2011cited by this paper
• MicroRNA and drug resistance

  2010cited by this paper
• Long non-coding RNAs: insights into functions

  2009cited by this paper
• MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.

  2008cited by this paper
• Mechanisms of resistance to cisplatin and carboplatin.

  2007cited by this paper
• A biochemical approach to identifying microRNA targets

  2007cited by this paper
• A novel role for Bcl‐2 associated‐athanogene‐1 (Bag‐1) in regulation of the endoplasmic reticulum stress response in mammalian chondrocytes

  2007cited by this paper
• Human RISC couples microRNA biogenesis and posttranscriptional gene silencing.

  2005cited by this paper
• International lung cancer trends by histologic type: Male:Female differences diminishing and adenocarcinoma rates rising

  2005cited by this paper
• Cloning and Functional Analysis of BAG-l: A Novel Bcl-2-Binding Protein with Anti-Cell Death Activity

  2004cited by this paper
• Cisplatin: mode of cytotoxic action and molecular basis of resistance

  2003cited by this paper
• BAG-1: a multifunctional regulator of cell growth and survival.

  2003cited by this paper
• Relationship of XIST expression and responses of ovarian cancer to chemotherapy.

  2002cited by this paper
• A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome

  1991cited by this paper

• Epigenetic mechanisms in non-small cell lung cancer therapy and chemoresistance.

  2025cites this paper
• Natural Products and LncRNAs in Non‐Small Cell Lung Cancer: Emerging Therapeutic Approaches

  2025cites this paper
• Non-coding RNAs regulating programmed cell death and its implications in cancer chemotherapy resistance.

  2025cites this paper
• A review of the complex interplay between chemoresistance and lncRNAs in lung cancer

  2024cites this paper
• Comprehensive review of LncRNA-mediated therapeutic resistance in non-small cell lung cancer

  2024cites this paper
• “Crosstalk between non-coding RNAs and transcription factor LRF in non-small cell lung cancer”

  2024cites this paper
• LncRNA HAR1A inhibits non-small cell lung cancer growth by downregulating c-MYC transcripts and facilitating its proteasomal degradation.

  2024cites this paper
• XIST as a modulator of chemotherapy resistance in cancers

  2024cites this paper
• GATA1 activates HSD17B6 to improve efficiency of cisplatin in lung adenocarcinoma via DNA damage

  2024cites this paper
• CircRNA ZKSCAN1 promotes lung adenocarcinoma progression by miR‐185‐5p/TAGLN2 axis

  2023cites this paper
• lncRNA-disease association prediction based on the weight matrix and projection score

  2023cites this paper
• Long non-coding RNA and Evolving drug resistance in lung cancer

  2023cites this paper
• Mechanism of PWAR6 regulating cisplatin drug sensitivity in non-small cell lung cancer through miR-577/PHACTR1.

  2023cites this paper
• Dual mechanism of Let-7i in tumor progression

  2023cites this paper
• Role of long non-coding RNAs in cancer: From subcellular localization to nanoparticle-mediated targeted regulation

  2023cites this paper
• Potential roles of lncRNA-XIST/miRNAs/mRNAs in human cancer cells

  2023cites this paper
• Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review

  2022cites this paper
• LncRNA-AC009948.5 promotes invasion and metastasis of lung adenocarcinoma by binding to miR-186-5p

  2022cites this paper
• MARCKSL1–2 reverses docetaxel-resistance of lung adenocarcinoma cells by recruiting SUZ12 to suppress HDAC1 and elevate miR-200b

  2022cites this paper
• Cellular and Molecular Mechanism of Cell Proliferation in Human Gastric Cancer Drug-Resistant Cells After Hyperthermia and Cisplatin: Role of mRNAs and Long-Non-coding RNAs.

  2022cites this paper
• BAG family proteins contributes to autophagy-mediated multidrug resistance of tumor

  2022cites this paper
• Long noncoding RNA LINC01287 promotes proliferation and inhibits apoptosis of lung adenocarcinoma cells via the miR‐3529‐5p/RNASEH2A axis under the competitive endogenous RNA pattern

  2021cites this paper
• GINS2 was regulated by lncRNA XIST/miR-23a-3p to mediate proliferation and apoptosis in A375 cells

  2021cites this paper
• LncRNAs and miRNAs participate in determination of response of cancer cells to cisplatin.

  2021cites this paper
• Clinical impact of LncRNA XIST and LncRNA NEAT1 for diagnosis of high-risk group breast cancer patients.

  2021cites this paper
• Competing endogenous RNAs in lung cancer

  2021cites this paper
• lncRNA GAS6-AS2 regulates paclitaxel sensitivity in lung cancer A549 cells by targeting miR-125a-3p

  2021cites this paper
• Long Noncoding RNA ZEB1-AS1 Downregulates miR-23a, Promotes Tumor Progression, and Predicts the Survival of Oral Squamous Cell Carcinoma Patients

  2021cites this paper
• Biological Function of Long Non-coding RNA (LncRNA) Xist

  2021cites this paper
• X-Inactive-Specific Transcript: Review of Its Functions in the Carcinogenesis

  2021cites this paper
• Long non-coding RNA XIST promotes cerebral ischemia/reperfusion injury by modulating miR-27a-3p/FOXO3 signaling

  2021cites this paper
• lncRNA-Disease Association Prediction Based On Weight Matrix And Projection Score

  2021cites this paper
• Long non-coding RNA X-inactive specific transcript promotes osteosarcoma metastasis via modulating microRNA-758/Rab16

  2021cites this paper
• Long Non-coding RNAs in Pathogenesis of Neurodegenerative Diseases

  2021cites this paper
• LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis

  2021cites this paper
• Long non-coding RNA XIST: a novel oncogene in multiple cancers

  2021influential citation
• LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis

  2021cites this paper
• LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis

  2020cites this paper
• The role of long non‐coding RNAs in drug resistance of cancer

  2020cites this paper
• lncRNA RP11-838N2.3 Promoted Cisplatin Resistance in Lung Adenocarcinoma

  2020cites this paper
• Long non‐coding RNA XIST binding to let‐7c‐5p contributes to rheumatoid arthritis through its effects on proliferation and differentiation of osteoblasts via regulation of STAT3

  2020cites this paper
• MicroRNA let-7i Inhibits Histone Lysine Demethylase KDM5B to Halt Esophageal Cancer Progression

  2020cites this paper
• SNHG17 upregulates WLS expression to accelerate lung adenocarcinoma progression by sponging miR-485-5p.

  2020cites this paper
• The Role of Long Non-Coding RNA NNT-AS1 in Neoplastic Disease

  2020cites this paper
• XIST: A Meaningful Long Noncoding RNA in NSCLC Process.

  2020cites this paper
• Silencing lncRNA DUXAP8 inhibits lung adenocarcinoma progression by targeting miR-26b-5p

  2020cites this paper
• Long non-coding RNA X-inactive specific transcript silencing ameliorates primary graft dysfunction following lung transplantation through microRNA-21-dependent mechanism

  2020cites this paper
• LncRNA MSC-AS1 facilitates lung adenocarcinoma through sponging miR-33b-5p to up-regulate GPAM.

  2020cites this paper
• LncRNA XIST acts as a MicroRNA-520 sponge to regulate the Cisplatin resistance in NSCLC cells by mediating BAX through CeRNA network

  2020cites this paper
• Silencing of lncRNA XIST inhibits non-small cell lung cancer growth and promotes chemosensitivity to cisplatin

  2020cites this paper
• The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents

  2020cites this paper
• Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs.

  2020cites this paper
• miR‐142‐5p protects against osteoarthritis through competing with lncRNA XIST

  2020cites this paper
• Cell Biology International

  2020cites this paper
• Role of non-coding RNAs and RNA modifiers in cancer therapy resistance

  2020cites this paper
• A BAG's life: Every connection matters in cancer.

  2020cites this paper
• Long non‐coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR‐363‐3p

  2020cites this paper
• CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p.

  2020cites this paper
• LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621.

  2019cites this paper
• TCF-4 Regulated lncRNA-XIST Promotes M2 Polarization Of Macrophages And Is Associated With Lung Cancer

  2019cites this paper
• FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14

  2019cites this paper
• Beyond X-Chromosome Inactivation: The Oncogenic Facet of XIST in Human Cancers

  2019cites this paper
• [Long non-coding RNA XIST modulates cisplatin resistance by altering PDCD4 and Fas-Lexpressions in human nasopharyngeal carcinoma HNE1 cells in vitro].

  2019cites this paper
• Identification of lncRNA–miRNA–mRNA regulatory network associated with epithelial ovarian cancer cisplatin‐resistant

  2019cites this paper
• RETRACTED ARTICLE: Long non-coding RNA GAS5 sensitizes renal cell carcinoma to sorafenib via miR-21/SOX5 pathway

  2019cites this paper
• Silencing of long noncoding RNA XIST attenuated Alzheimer's disease‐related BACE1 alteration through miR‐124

  2019cites this paper
• lncRNA SNHG7 affects malignant tumor behaviors through downregulation of EZH2 in uveal melanoma cell lines

  2019cites this paper
• OTT_A_210952 8055..8062

  2019cites this paper
• LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin/Fak/Src signaling

  2018cites this paper
• The Long Intergenic Noncoding RNA 00707 Promotes Lung Adenocarcinoma Cell Proliferation and Migration by Regulating Cdc42

  2018cites this paper
• Long non‐coding RNA FTH1P3 activates paclitaxel resistance in breast cancer through miR‐206/ABCB1

  2018cites this paper
• The long non-coding RNA SNHG5 regulates gefitinib resistance in lung adenocarcinoma cells by targetting miR-377/CASP1 axis

  2018cites this paper